A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Rusch
Valerie W
VW
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D017322:Clinical Trials, Phase II as Topic; D003131:Combined Modality Therapy; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D008654:Mesothelioma / Q000628:therapy*; D010994:Pleura / Q000601:surgery; D010997:Pleural Neoplasms / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D012107:Research Design
D007376:Interleukin-2